🇺🇸 FDA

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

2,636 results for “-” Clear

  1. recombinant respiratory syncytial virus pre-fusion f protein, adjuvanted with as01e

    AREXVY

    EMA: approved

    J07BX05

  2. recombinant salmon calcitonin

    FORCALTONIN

    EMA: withdrawn

    H05BA01

  3. reduced-dose

    NMPA: clinical trials

  4. regorafenib hydrate

    STIVARGA INITIAL APPROVAL

    PMDA: approved

  5. relugolix + estradiol + norethisterone acetate

    RYEQO Gedeon Richter Australia Pty Ltd

    TGA: approved

  6. remifentanil hydrochloride

    REMIFENTANIL HYDROCHLORIDE

    INJECTION FDA: approved

  7. remimazolam besylate

    BYFAVO

    INTRAVENOUS FDA: approved

  8. renin-angiotensin

    NMPA: clinical trials

  9. repository corticotropin

    H.P. ACTHAR GEL

    INJECTION FDA: approved

  10. respiratory syncytial virus mrna vaccine

    MRESVIA Teva Pharma GmbH

    EMA: approved

    J07BX05

  11. respiratory syncytial virus rna vaccine

    MRESVIA

    PMDA: approved

  12. respiratory syncytial virus vaccine (bivalent, recombinant)

    ABRYSVO

    EMA: approved

    J07BX05

  13. retifanlimab-dlwr

    ZYNYZ

    INTRAVENOUS FDA: approved

  14. revumenib citrate

    REVUFORJ Syndax Pharmaceuticals

    ORAL FDA: approved

  15. rezafungin acetate

    REZZAYO

    INTRAVENOUS FDA: approved

  16. rhg-csf

    NMPA: clinical trials

  17. rhgm-csf

    NMPA: clinical trials

  18. rhtnk-tpa

    NMPA: clinical trials

  19. ribociclib succinate

    KISQALI

    ORAL FDA: approved

  20. riboflavin 5'-phosphate

    PHOTREXA VISCOUS IN DEXTRAN 20%

    OPHTHALMIC FDA: approved

  21. riboflavin 5'-phosphate sodium

    PHOTREXA VISCOUS IN DEXTRAN 20%/PHOTREXA

    OPHTHALMIC FDA: approved

  22. ric-conditioning

    NMPA: clinical trials

  23. rifamycin sodium

    AEMCOLO

    ORAL FDA: approved

  24. rilpivirine hydrochloride

    RILPIVIRINE HYDROCHLORIDE

    ORAL FDA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources